跳至主要内容
临床试验/NCT02269449
NCT02269449Unknown不适用

RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial)

NPO International TRI Network0 个研究点目标入组 1,900 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,900
主要终点
Radial artery occlusion

研究概览

简要总结

The objectives of this study are to demonstrate the safety and efficacy of the new 6Fr sheath (Glidesheath slender; Terumo, Tokyo,Japan ; GSS) compared with the contemporary 5Fr sheath (Hydrophilic coating sheath from Terumo; Tokyo, Japan (standard of care ; SOC).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is able to verbally acknowledge an understanding of the associated risks, benefits and treatment alternatives and he or his legally authorized representative provides written informed consent prior to the randomization, as approved by the appropriate IRB.
  • Patient who is expected to diagnose by coronary artery angiography or followed by PCI.
  • Patient must agree to undergo all protocol-required follow-up examinations.
  • Patient who can accept radial access.

排除标准

  • Patient has other medical illness (e.g., cancer or congestive heart failure) that may cause non-compliance with the protocol, confound the data interpretation or is associated with a limited life expectancy (i.e., less than one year).
  • Hemodialysis patient

结局指标

主要结局

Radial artery occlusion

时间窗: Day 1

Local bleeding from puncture site

时间窗: Day 1

次要结局

  • Vascular access site complication(Day 1)
  • Procedure success rate(Day 1)
  • Radial spasm during the index procedure(Day 1)
  • Total Procedure Time(Day 1)
  • Pain score(Day 1)
  • Total Radiation Doses(Day 1)
  • Device failure for the assigned sheath introducer(Day 1)
  • Total Amount of Contrast Dye(Day 1)

研究者

发起方
NPO International TRI Network
申办方类型
Network
责任方
Sponsor

相似试验